≥99%
86168-78-7
3357.88 g/mol
Sermorelin
Sermorelin is a 29-amino acid synthetic peptide analog of GHRH(1-29) supplied for in-vitro receptor-activation assays, structural analysis, and analytical method development.
1 vial × $45 each
Add 3+ to unlock
volume pricing
Pay with Visa, Mastercard, or AMEX · ACH bank transfer saves 5%
Free US shipping on orders over $200, with tracking provided.
Third-party tested
Supplied to qualified labs and institutional buyers. Institutional use & buyer eligibility
Characteristics
| Property | Value |
|---|---|
| Molecular Formula | C₁₄₉H₂₄₆N₄₄O₄₂S |
| CAS Number | 86168-78-7 |
| Molar Mass | 3357.88 g/mol |
| Amino Acid Sequence | Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ |
| Synonyms | GHRH (1-29), GRF (1-29) NH₂, Sermorelin acetate |
| Physical Form | Lyophilized powder |
| Solubility | Soluble in water and aqueous laboratory solvent |
| Organoleptic Profile | White to off-white lyophilized powder; odorless |
| Storage Conditions | Store lyophilized at -20°C; reconstituted solution stable at 2-8°C for up to 14 days |
| Composition | Lyophilized sermorelin acetate |
How is Sermorelin Used in Research?
Sermorelin is a 29-amino acid synthetic peptide analog of GHRH(1-29), supplied as a lyophilized reference standard for in-vitro receptor-activation assays, structural analysis, and analytical method development. The 29-residue sequence corresponds to the N-terminal fragment of endogenous growth hormone-releasing hormone and is the minimal sequence that retains full binding activity at the GHRH receptor.
At the molecular level, sermorelin is studied as a GHRH-receptor ligand in in-vitro receptor-binding assays conducted in anterior pituitary somatotroph cell-culture systems. Binding activates the Gs-adenylyl cyclase-cAMP-PKA signaling cascade, which is tracked with standard biochemical readouts (cAMP accumulation assays, PKA-substrate phosphorylation panels). Supplied for laboratory characterization only. Not for use in any living organism.
Researchers use sermorelin as a reference compound in analytical method development — HPLC and mass-spectrometry identity assays, purity-profile characterization, and comparability work against newer GHRH analogs. In-vitro receptor-activation assays and structural analysis (circular dichroism, NMR conformational studies) represent the principal laboratory use cases for this research standard.
This product is supplied in a lyophilized form and requires reconstitution prior to laboratory handling. For research and laboratory use only. Not for human or veterinary consumption.
Areas of Study
In-Vitro Receptor-Activation Assays
Used as a GHRH-receptor reference ligand in cAMP accumulation assays on cultured somatotroph cell lines and recombinant GHRH-R expression systems.
Structural Analysis
Characterized by circular dichroism, NMR, and mass spectrometry to profile secondary-structure content and counter-ion composition.
Analytical Method Development
Applied as an identity and purity reference standard in HPLC assay development and comparability testing against newer GHRH analogs.
Receptor-Binding Studies
Employed in competitive binding assays to profile GHRH-R affinity of novel analogs and truncation mutants in cell-culture systems.
Reference Compound Use
Serves as a historical reference GHRH(1-29) standard for comparability and analytical characterization in laboratory workflows.
References
- [1]Walker RF. (2006). Sermorelin: a review of GHRH (1-29) as a research tool in growth hormone axis physiology. Clinical Interventions in Aging, 1(4), 307-308.
- [2]Gaylinn BD, Thorner MO. (2001). GHRH receptors, secretagogue receptors, and growth hormone secretion. Growth Hormone & IGF Research, 11(Suppl A), S35-S38.
- [3]Alba M, Fintini D, Bowers CY, et al. (2005). Effects of GHRH and GHRP-6, alone and in combination, on GH secretion in aged rats. Journal of Endocrinology, 185(3), 543-551.
Disclaimer: The information provided is for research reference only and does not constitute medical advice. Products are sold strictly for in-vitro research use.
Certificate of Analysis (COA)
Third-Party Verified Quality
Every batch of Sermorelinis independently tested by an A2LA-accredited (ISO 17025:2017) third-party laboratory using HPLC-UV/VIS for purity and measured quantity. Each COA carries the lab's signed report and a batch-specific lot number. We publish these results publicly so you can verify exactly what you're getting.
View Lab ResultsRelated Products
GIP3
10mg – 30mg
Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors in preclinical metabolic studies.
CJC-1295 (no DAC)
5mg – 10mg
CJC-1295 is a 30-amino acid synthetic GHRH analog with a Drug Affinity Complex modification, supplied for in-vitro receptor-binding and half-life characterization studies.
Ipamorelin
5mg – 10mg
Ipamorelin is a 5-amino acid synthetic peptide growth hormone secretagogue supplied for in-vitro GHS-R1a receptor-binding assays and selectivity profiling.
Tesamorelin
5mg – 10mg
A synthetic GHRH analog supplied as a lyophilized reference standard for in-vitro GHRH-receptor-binding assays, selectivity profiling, and analytical method development. Not for use in any living organism.
Frequently Bought Together
Sermorelin
5mg
$45
GIP3
10mg
$100
CJC-1295 (no DAC)
5mg
$45
Bundle total
$190